Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2008-3118
2. Registrant Information.
Registrant Reference Number: Prosar case 1-16413142
Registrant Name (Full Legal Name no abbreviations): Scotts Canada Ltd
Address: 2000 Argentia Road Plaza 5 Suite 101
City: Mississauga
Prov / State: Ontario
Country: Canada
Postal Code: L5N2R7
3. Select the appropriate subform(s) for the incident.
Human
4. Date registrant was first informed of the incident.
17-JUL-08
5. Location of incident.
Country: CANADA
Prov / State: ALBERTA
6. Date incident was first observed.
13-JUL-08
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 27801
PMRA Submission No.
EPA Registration No.
Product Name: Killex Lawn Weed Control Concentrate (Green Cross)
- Active Ingredient(s)
- 2,4-D (PRESENT AS AMINE SALTS : DIMETHYLAMINE SALT, DIETHANOLAMINE SALT, OR OTHER AMINE SALTS)
- DICAMBA (PRESENT AS ACID, AMINE SALT, ESTER, OR SODIUM SALT)
- MECOPROP-P (PRESENT AS DIMETHYLAMINE SALT)
7. b) Type of formulation.
Application Information
8. Product was applied?
Yes
9. Application Rate.
Unknown
10. Site pesticide was applied to (select all that apply).
Site: Res. - Out Home / Rés - à l'ext.maison
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
The product was applied on 7/13/08. The reporter and her husband were out all day spraying the yard with the product.
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform II: Human Incident Report (A separate form for each person affected)
1. Source of Report.
Data Subject
2. Demographic information of data subject
Sex: Female
Age: Unknown / Inconnu
3. List all symptoms, using the selections below.
System
4. How long did the symptoms last?
Unknown / Inconnu
5. Was medical treatment provided? Provide details in question 13.
Unknown
6. a) Was the person hospitalized?
Unknown
6. b) For how long?
7. Exposure scenario
Non-occupational
8. How did exposure occur? (Select all that apply)
Application
9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)
Unknown
10. Route(s) of exposure.
Unknown
11. What was the length of exposure?
>2 hrs <=8 hrs / >2 h <=8 h
12. Time between exposure and onset of symptoms.
>2 hrs <=8 hrs / > 2 h < = 8 h
13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)
1-16413142: The reporter called on 7/17/08 to report the exposure of herself and her husband to a product containing the active ingredients Mecoprop, Dicamba, and 2,4,D. According to the reporter, she and her husband had been spraying their yard with the product all day on 7/13/08. Since that time, they both have had stomach cramps when they eat. In addition, the reporters husband had developed painful, frequent episodes of urination (to the point of incontinence) in which the urine had been a bright yellow color. Both the reporters and her husbands symptoms had continued for 4 days without improvement. The safety profile of the product was discussed. While very large prolonged exposure to the product could result in stomach upset, the symptoms would not be expected to continue for more than 24 hours. Additionally, urinary issues would not be expected to develop after routine product use. A recommendation was made to seek medical care since the symptoms had continued for more than 24 hours. A follow-up call was placed but was never returned.
To be determined by Registrant
14. Severity classification.
Minor
15. Provide supplemental information here.
Subform II: Human Incident Report (A separate form for each person affected)
1. Source of Report.
Medical Professional
2. Demographic information of data subject
Sex: Male
Age: Unknown / Inconnu
3. List all symptoms, using the selections below.
System
- Renal System
- Symptom - Urine discoloration
- Specify - Discolored urine (bright yellow)
- Symptom - Painful urination
- Symptom - Frequent urination
- Symptom - Urinary incontinence
4. How long did the symptoms last?
Unknown / Inconnu
5. Was medical treatment provided? Provide details in question 13.
Unknown
6. a) Was the person hospitalized?
Unknown
6. b) For how long?
7. Exposure scenario
Non-occupational
8. How did exposure occur? (Select all that apply)
Application
9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)
Unknown
10. Route(s) of exposure.
Unknown
11. What was the length of exposure?
>2 hrs <=8 hrs / >2 h <=8 h
12. Time between exposure and onset of symptoms.
>2 hrs <=8 hrs / > 2 h < = 8 h
13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)
1-16413142: The reporter called on 7/17/08 to report the exposure of herself and her husband to a product containing the active ingredients Mecoprop, Dicamba, and 2,4,D. According to the reporter, she and her husband had been spraying their yard with the product all day on 7/13/08. Since that time, they both have had stomach cramps when they eat. In addition, the reporters husband had developed painful, frequent episodes of urination (to the point of incontinence) in which the urine had been a bright yellow color. Both the reporters and her husbands symptoms had continued for 4 days without improvement. The safety profile of the product was discussed. While very large prolonged exposure to the product could result in stomach upset, the symptoms would not be expected to continue for more than 24 hours. Additionally, urinary issues would not be expected to develop after routine product use. A recommendation was made to seek medical care since the symptoms had continued for more than 24 hours. A follow-up call was placed but was never returned.
To be determined by Registrant
14. Severity classification.
Moderate
15. Provide supplemental information here.